Matsuo, Koji
Chavez, Robert Dalton
Barruet, Emilie
Hsiao, Edward C.
Article History
First Online: 13 November 2019
Compliance with Ethical Standards
:
: Edward Hsiao serves on the registry advisory board of the International Fibrodysplasia Ossificans Progressiva Association, is on the International Clinical Council on FOP, and is on the Fibrous Dysplasia Foundation Medical Advisory Board. ECH receives clinical trials research support through his institution from Clementia Pharmaceuticals Inc. to support clinical trials of palovarotene in FOP. ECH previously received clinical trials support through his institution from Regeneron Pharmaceuticals, Inc. These pose no conflicts for this study.Koji Matsuo, Robert Dalton Chavez, and Emilie Barruet declare that they have no conflicts of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.